← FDA Drug Approvals (Drugs@FDA)

IRESSA

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2003-05-05

Drug application

FDA Application #

NDA021399

Application type

New Drug Application

Brand name

IRESSA

Generic name

Gefitinib

Active ingredients

GEFITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ASTRAZENECA

First approval

2003-05-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown